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CHAPTER fOURTEEN 
Division of Rheumatology
 
NATHAN M. SMUKLER, M.D. 
"The rheumatism is a common name for 
many aches and pains~ which have yet 
got no peculiar appellation~ though 
owing to very different causes.~~ 
As THE various subspecialties of internal medicine evolved, rhewnatology developed comparatively late. In the immediate 
decades preceding and following World War II, 
Departments of Medicine of United States medical 
colleges generally adopted divisional or sectional 
formats. During this organizational period 
such established subspecialites as cardiology, 
gastroenterology, and hematology took priority, 
and at many institutions rheumatology was either 
present on a very small scale or nonexistent. In the 
I950S and 60S, however, there occurred a surge of 
interest in rhewnatology, and this subspecialty 
became an organized entity at many institutions. 
Among the factors that contributed to this 
rapid development of rheumatology were the 
discovery of the antiinflammatory properties of 
glucocorticoids by Hench and co-workers at the 
Mayo Clinic, the explosion of new knowledge in 
the field of immunology, the National Institutes of 
Health research and training grants, and the trend 
to subspecialization by internists during the post­
World War II era. 
At Jefferson the divisional organization of the 
Deparunent of Medicine occurred during the 
-WILLIAM HEBERDEN (1710-1801) 
tenure of Dr. Robert 1. Wise as Chairman (1959­
1975). In the forming of Divisions, rhewnatology 
was among the last. Nevertheless, an arthritis 
clinic was established at Jefferson Hospital in [931 
and preceded the establishment of the Division by 
28 years. Even before these events, a nwnber of 
Jeffersonians made contributions to this specialty. 
Early Rheumatology at Jefferson 
In 1880, Roberts Bartholow, Professor of Materia 
Medica, wrote an elegant detailed description of 
the rhewnatic diseases that constituted a chapter 
of his textbook Practice ofMedicine. I Dr. 
Bartholow was born in 1831, received his M.D. 
degree from the University of Maryland, and was 
a member of the active faculty at Jefferson from 
1879 to 1891. He died in 1904. Teaching and clinic 
activities at Jefferson did not deter him from 
writing; his bibliography included numerous 
articles and the sole authorship of a textbook of 
therapeutics, as well as the one of medicine. 
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Bartholows chapter devoted to rheumatism was 
divided into discussions of acute and chronic joint 
disease. The portion on acutc rheumatism was 
entirely concerned with rheumatic fever, a disease 
known also at the time as articular rheumatism 
and polyarthritis rheumatica. In his clinical 
description of the arthritis of rheumatic fever he 
detailed its migratory course, the tendency to 
involve large rather than small joints, and its 
limited duration of four to six weeks. Also cited 
was the propensity of those complicated with 
carditis to develop chronic heart disease later in 
life. Erythema marginatum and chorea were not 
mentioned. Although the temporal relationship of 
rhematic fever and scarlet fever was discussed, 
there is no indication of appreciation that acute 
pharyngitis frequently preceded this disease. 
Bartholows lucid discussion of the differential 
diagnosis of rheumatic fever is entirely valid after 
the lapse of a century. It included pyaemia (septic 
arthritis), rheumatoid arthritis, acute gout, urethral 
rheumatism (gonococcal urethritis and Reiter's 
syndrome), and hysterical joint disease. A variety 
of treatment modalities were described, but only 
salicylate is still in use. Salicylate was described as 
being very effective, but its use caused 
gastrointestinal complications, tinnitus, and 
depression of the heart. Possibly the cardiotoxic 
properties attributed to salicylate reflected the 
carditis of rheumatic fever. However, the concept 
that "aspirin is bad for the heart" persisted, and 
many patients some 70 and 80 years later refused 
aspirin for this reason. 
In his discussion of chronic joint disease, 
Bartholow presented three categories: chronic 
rhetill1atisDl, gout, and arthritis deformans. 
Chronic rheumatism was identified as a joint 
disorder developing in patients beyond middle 
age, marked by stiffness, particularly in the 
morning, intermittent swelling, and rarely joint 
inflan1ffiation. His "chronic rheumatism" appeared 
to be that portion of the spectrum of arthritis that 
is presently classified as osteoarthritis. It is of 
interest, however, that he failed to touch upon a 
key point of osteoarthritis, the predilection of the 
disease to involve the distal joints of the fingers, 
the hips, the knees, and the low spine. 
Gout was classified as a chronic disease, 
although the acute episodes of arthritis that may 
precede or be superimposed upon the chronic 
involvement were described in detai1. Bartholow 
listed obesity and lead nephropathy (saturnine 
gout) as factors that predispose to gout and 
also discussed the association of gout and 
atherosclerosis. Colchicine and salicylate were 
advocated for the treatment of acute gouty 
arthritis. After the passage of a century colchicine 
is still utilized for treatment and prophylaxis of 
this phase of gout. Also, today it is appreciated 
that weight reduction may lower the serum uric 
acid. Thus there is a rational basis for Bartholow's 
empiric recommendation of a sparse diet featuring 
fruits and vegetables and regular exercise in the 
treatment of this disease. 
The final group of patients presented in 
Bartholows chronic rheumatism section were 
those with destructive inflan1ffiation of multiple 
joints. They were discussed under the heading of 
arthritis deformans, which he favored over 
"rheumatoid arthritis," the term coined by the 
English physician Garrod to describe similar 
patients. Bartholow's arthritis deformans patients 
included those with limb joint involvement and 
also those with rigidity of the spine. These 
patients by present-day criteria would be 
categorized as having rheumatoid arthritis and 
ankylosing spondylitis, respectively. 
In 1882, Morris Longstreth (184-6-1914-), 
Professor of Pathological Anatomy at Jefferson, 
authored a monograph concerned with rheumatic 
diseases. Dr. Longstreth was born and raised in 
the Philadelphia area and received an A.B. degree 
from both Haverford and Harvard Colleges 
and an M.D. degree from the University of 
Pennsylvania. He became a Resident at the 
Pennsylvania Hospital, where he developed an 
interest in both pathology and the rheumatic 
diseases. 2 After his residency he continued at the 
Pennsylvania Hospital as Attending Physician and 
Curator of the Pathological Museum. He was 
appointed Professor of Pathological Anatomy at 
JefIerson in 1879 and retained this position until 
1895, when he resigned to enter private practice in 
Philadelphia. The Willian1 Wood publishing firm 
in New York City encouraged Dr. Longstreth to 
make known his knowledge of the rheumatic 
diseases and he responded with a monograph of 
279 pages. 3 
The first few chapters of Longstreth's text, 
entitled Gout) Rheumatis1n and Some Allied 
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Disorders) were concerned with the spectrum of 
rheumatic diseases, including etiology and 
pathology. The middle and largest portion of the 
volume was devoted to the clinical, laboratory, 
and pathological aspects of rheumatic fever, which 
at the time of publication was the most prevalent 
of the acute rheumatic diseases. The emphasis on 
rheumatic fever is of interest in that present-day 
medical students are unlikely to encounter this 
disease except in relation to residual valvular heart 
disease. 
Longstreth's chapter devoted to rheumatic fever 
gave an excellent description of acute arthritis 
associated with this disease. He and his 
contemporaries had a good understanding of 
rheumatic heart disease. They appreciated that 
there was involvement of the pericardium, 
myocardium, and endocardium. Although 
auscultation permitted clinical detection of 
endocarditis, the myocardial and pericardial disease 
was generally demonstrated at postmortem 
examination. Finally, it was clearly described that 
some patients with acute endocarditis went on to 
recovery, whereas others developed severe 
progressive and ultimately fatal heart disease. 
Longstreth noted that acute rheumatic fever was 
more common among the poor than in those 
from the higher economic classes, an observation 
that was made again in this country some 50 years 
later. 
A chapter of Longstreth's book was devoted to 
central nervous system complications of rheumatic 
fever. He described neuropathological findings in 
the meninges and brain and also neural symptoms 
that were considered to reflect systemic aspects of 
the disease such as fever. For example, he quoted 
Dr. Jacob Mendes DaCosta of the Jefferson 
faculty, who reported that a patient may develop 
cerebral rheumatism during or shortly after an 
attack of rheun1atic fever. 4 Cerebral rheumatism 
was described as a restlessness passing into stupor, 
coma, or delirium and terminating in death. 
In some of these patients there were focal 
neurological findings as seizures, palsies, or 
hemiplegia. This material is difficult to reconcile 
with present-day concepts of the central nervous 
system involvement in rhematic fever, which is 
limited to the basal ganglia, expressed as chorea. 
In fairness to Longstreth it is to be noted he 
indicated that the meninges and cerebral disease 
described in these rheumatic fever patients may 
have been due to a complicating disease such as 
meningitis rather than the rheumatic fever. In 
hindsight the "cerebral rheumatism" may have 
represented systemic lupus erythematosus that was 
not delineated from rheumatic fever, or even a 
phase of rheumatic fever no longer encountered. 
With respect to treatment, salicylate in various 
forms was recommended as being effective in 
management of the arthritis but not the carditis of 
rheumatic fever. A quote from Longstretll 
concerning salicylic acid is of interest in view 
of tlle fact that many present-day physicians 
favor salicylates over the other nonsteroidal 
antiinflammatory drugs, as they are effective and 
less expensive. "The acid (salicylic acid) has been 
known since 1844 when it was prepared from oil 
of wintergreen. Its scarcity and great cost 
prevented its use and its quality remained to a 
great degree unknown." He goes on to state that 
in the ensuing years manufacturing techniques 
improved, and the drug became less expensive. 
Longstretll's last chapters were devoted to 
chronic articular rheumatism (osteoarthritis), gout, 
and gonorrheal arthritis. Of particular interest is 
the description of the natural course of gonococcal 
arthritis in the prepenicillin era. The attack of 
arthritis might last for weeks or months, and in 
some instances there was progression to chronic 
effusion, fibrous involvement, and fibrous 
ankylosis. In contrast to present-day rheumatology 
textbooks, which give top priority to rheumatoid 
arthritis, Dr. Longstreth was cursory in his 
approach to this disease and considered it 
primarily in subsections devoted to the differential 
diagnosis of arthritis. Factors to be considered in 
the rise in importance of rheumatoid arthritis over 
the course of a century include the virtual 
disappearance of rheumatic fever in the United 
States and Western European countries, the 
development of laboratory and radiographic 
techniques that facilitate the delineation of 
rheumatoid arthritis from other rheumatic diseases, 
and possibly an increased prevalence of 
rheumatoid arthritis in recent decades. 
In 1886 representatives from Philadelphia 
hospitals presented their treatment programs for 
the rheumatic diseases.s Drs. J. M. DaCosta 
and Bartholow represented Jefferson, and Dr. 
Longstreth the Pennsylvania Hospital, although 
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he also held a Professorship at Jefferson. The 
renowned Dr. William Osler of the University of 
PelU1sylvania Hospital and Dr. James Tyson of the 
Philadelphia Hospital (Philadelphia General 
Hospital) also contributed. The main focus on the 
discussion was directed to rheumatic fever. It was 
generally agreed that salicylatcs were useful in 
controlling the articular but not the cardiac 
manifestations. For joint pain, opium or one of its 
derivatives was advocated both systemically and by 
local application. 
In 1914- Dr. Solomon Solis-Cohen (Figure 14--1) 
(Jefferson, 1883), Professor of Clinical Medicine, 
authored a paper6 that represented the first report 
in the English literature of the rheumatic entity 
now termed palindromic arthritis. It is an episodic 
disorder marked by attacks of pain and swelling of 
joints or tissues adjacent to joints, lasting for a day 
or a few days, with variable intervals between 
attacks. After months or years the attacks may 
cease. At times, however, they may be a harbinger 
of rheumatoid arthritis. Dr. Solis-Cohen's report 
reviewed a series of patients, many of whom 
manifested an episodic disorder consistent with 
palindromic arthritis. He attributed the articular 
and periarticular involvement to an autonomic 
imbalance, which he termed vasomotor or 
autonomic ataxia; however, at present this 
condition is considered to reflect a disorder of the 
immune system. He also published many 
additional reports dealing with clinical features or 
treatment of rheumatic disease.7-9 
Dr. Abraham Cohen (Figure 14--2) was one of 
the pioneer rheumatologists in the United States. 
Cohen (Jefferson, 1925) was a member of the staff 
of Jefferson Hospital with special interest in its 
arthritis clinic from 1931 lU1til his death in 1969. In 
addition, he was active at the Philadelphia General 
Hospital and headed an arthritis clinic at that 
hospital for many years. Dr. Cohen's hospital 
appointments and bibliography demonstrate his 
FIG. 14--1. Solomon Solis-Cohen, M.D., Professor of 
Clinical Medicine (1904--1927) and Jefferson pioneer in FIG. 14-2. Abraham Cohen, M.D., innovative organizer of 
treatment of "rheumatic disorders." Jefh:rson's first arthritis clinic (1931). 
350. Thomas JeJJerson University 
Blizzard (Jefferson, 1954), and Leon Weiner 
participated in the Jefferson Arthritis Clinic. 
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capacity as tireless worker, astute ob~erver, and 
innovative therapist. In 1941 he published the first 
defmitive description of gouty arthritis in black 
Americans. 1O Before that time there was only one 
case report of gout in a black American, which 
had appeared in a Scandinavian journal. Cohen 
also authored 20 additional papers on a vanety of 
rheumatological topics. In the New Engl~nd . 
Journal ofMedicine) he det~iled his. eXPr~;Ience With 
gold therapy for rheumatoid a.rthntls.' He also 
reported a trial of an estrogemc s~~stance for 
the treatment of rheumatoid arthntIs. Several 
papers described his use of physostigmine and 
neostigmine for patients with musculoskeletal­
articular pain and muscle spasms, as well as 
histamine for those with impaired peripheral 
circulation.'3- '1 In the context of todays use of 
such immunosuppressive agents as az.athi~prine 
and methotrexate to manage connective tissue 
diseases, Dr. Cohen's effort with a trial of . 
nitrogen mustard for patients with rheumatOId 
arthritis was prophetic.16. . 
From 1946 until 1956 Dr. Richard T. Smith 
(Figure 14-3) (Jefferson, 1941) served as Chief of 
the Rheumatology outpatient clinic. He was a 
staunch advocate of gold therapy prior to the time 
that this agent was unequivocally establishe? as an 
effective therapeutic modality for rheumatoid 
arthritis. Subsequent to his activity at Jefferson 
Hospital, Dr. Smith was the ~ttendin~ 
Rheumatologist at Pennsylval1la Ho~pltal and also 
was active at the Merck PharmaceutICal Company. 
He died suddenly at age '58. . 
Dr. Irvin F. Hermann (Jefferson, 1937) aSSisted 
Dr. Smith at the arthritis clinic. Dr. Hermann's 
training included a fellowship with the eminent 
rheumatologist, Dr. Walter Bauer, at th~ . 
Massachusetts General Hospital. Followmg hIS 
fellowship, Dr. Hermann returned to Philadelphia 
and was active in rheumatology at Jefferson, at 
Mt. Sinai Hospital of Philadelphia (the Southern 
Division of the Albert Einstein Medical Center), 
and at Pennsylvania Hospital. He later served as 
Medical Director of the United States Postal 
Service. In addition, Drs. Roy G. Hays, Edward 
Mazur (Jefferson,' 1941), Howard Lorenz, John 
A Division of Rheumatology within the 
Department of Medicine was formed in July 1959, 
with Nathan M. Smukler (Jefferson, 1947) as 
Division Head. Dr. Smukler (Figure 14-4), who 
had trained at the Mt. Sinai Hospital of 
Philadelphia (now the Southern Division of the 
Albert Einstein Medical Center) and In 
rheumatology at the Hospital of the University of 
Pennsylvania under Dr. Joseph Hollander, was a 
member of the Department of Medicine a~ ~e 
University of Pennsylvania School of MedICIne 
before his appointment at Jefferson. . .. 
At the outset the only member of the DIVISIon 
of Rheumatology beside Dr. Smukler was Howard 
Lorenz, M.D., a volunteer faculty member who 
attended the arthritis clinic. It was thus necessary 
for Dr. Smuklcr to concentrate on teaching and 
patient care activities and to pu~ aside temporarily 
his research interests. The teachmg program 
included bedside teaching rounds at Jefferson 
Hospital, presentatio~1~ ofo~tpatients t? .stu~ents 
assigned to the arthntls clIme, and partICIpatiOn at 
medical grand rounds and formal lectures. 
A particular interest of Dr. Smukler wa.s the 
suspected role of psychological disorders m 
FIG. 14-3. Richard T. Smith, M.D., early advocate of gold 
therapy for rheumatoid arthritis. 
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provoking, sustaining, or aggravating rheumatoid 
arthritis and other systemic inflammatory 
rhewnatic diseases. It was envisioned that a group 
of psychologists, psychiatrists, and rhewnatologists 
could be organized to investigate this 
psychosomatic concept, and a request for support 
was submitted to the National Institutes of 
Health. Although this application was never 
funded, Dr. Smukler continued his observations of 
psychological factors upon the course of 
rhewnatoid arthritis and other chronic rheumatic 
diseases. Other areas of study included the 
neuroanatomy and neurophysiology of pain, 
nonorganic musculoskeletal-articular pain, systemic 
vasculitis, and spinal arthritis. 
Dr. John Abruzzo became the second full-time 
member of the Division in February, 1967. Before 
corning to Jefferson, Dr. Abruzzo (Figure 14--5), a 
graduate of Georgetown University School of 
Medicine, had been a resident in internal medicine 
at the Jersey City Medical Center, a Fellow in 
Rheumatology at the Columbia-Presbyterian 
Medical Center in New York City, and faculty 
member with the rank of Assistant Professor of 
Medicine at the New Jersey College of Medicine. 
During his fellowship at the Columbia­
Presbyterian Rheumatic Disease Unit under Dr. 
Charles Christian, Dr. Abruzzo collaborated in a 
study that showed that chronic injection of E. coli 
into dogs induced rheumatoid factor. 17 This 
pioneer work is among the factors that stimulated 
intensive research directed to uncovering an 
infectious etiology for rheumatoid arthritis. Mter 
coming to Jefferson, Dr. Abruzzo engaged in 
teaching, reorganized and directed the outpatient 
center, and carried out clinical testing of 
nonsteroidal antiinflammatory drugs in patients 
FIG. J4-4. Nathan M. Smukler, M.D., Chief of the FIG. 14-5. John 1" Abruzzo, M.D., Director, Division of 
Jefferson Rheumatology Division (1958-J980). Rheumatology (J980- ). 
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with rheumatoid arthritis and osteoarthritis. He 
also collaborated with Dr. Ralph Heimer, a 
member of the Department of Biochemistry, in 
the study of alterations of serum proteins in 
patients with various rheumatic diseases. In 1978 
Abruzzo was named Associate Editor of the 
Annals ofInternal Medicine. Dr. Abruzzo was 
promoted to Associate Professor of Medicine in 
1969 and to full Professor in 1974. He succeeded 
Dr. Smukler as Head of the Division in 1980. 
Dr. Ralph DeHoratius (Figure 14-6) (Jefferson, 
1968) becan1e the third ful1-time member of the 
Division in 1974. He had interned at Jefferson and 
subsequently served a residency in internal 
medicine and a fellowship in rheumatology at the 
University of New Mexico School of Medicine 
under Dr. Ralph Williams. Following completion 
of his training, Dr. DeHoratills joined the faculty 
of the University of New Mexico School of 
Medicine with the rank of Assistant Professor. At 
the time, he also received a career development 
award from the Veterans Administration, which 
enabled him to pursue research concerning 
pathogenetic immune mechanisms in connective 
tissue diseases. A particular interest of Dr. 
DeHoratius was detection of antibodies to 
lympho<....ytes that are concerned with immune 
regulatory mechanisms. He demonstrated their 
presence in patients with systemic lupus 
erythematosus, in their families and household 
pets, and in laboratory workers exposed to their 
blood. After returning to Jefferson as Assistant 
Professor of Medicine, DeHoratius received a 
young investigator award from the National 
Institutes of Health to continue his studies of 
defects in immune regulation in systemic lupus 
erythematosus patients and their contacts. He also 
developed an outpatient facility for evaluation 
and treatment of systemic lupus erythematosus 
patients. As a result of his productivity he rose to 
the rank of full Professor in 1982. In that year 
DeHoratius left Jefferson to accept a position as 
Director of an Immunology and Rheumatology 
Division in the Department of Medicine at 
Halmemann Medical College. 
During the 1950S and succeeding decades, 
intensive investigation indicated that 
immunological mechanisms contributed to the 
pathogenesis and perhaps the etiology of 
rheumatoid arthritis and other connective tissue 
diseases. Consequently, immunologically oriented 
research flourished at numerous rheumatology 
units throughout the United States. In an effort to 
facilitate this type of investigation at Jefferson, Dr. 
Frank Gray, the Magee Professor of Medicine 
(1976-1981), along with Drs. Abruzzo and 
DeHoratius, recruited Dr. J. Bruce Smith to join 
the Division in 1981. Dr. Smith, a graduate of the 
Bowman Gray School of Medicine, had trained in 
internal medicine at Pennsylvania Hospital and the 
University of Pennsylvania Hospital. He then 
became a Fellow in Immunology under Nobel 
Laureate Dr. Baruch Blumberg at the Institute for 
Cancer Research in Philadelphia and at University 
College, London, England, under Dr. N. A. 
Mitchison. 
Following his training in immunology, Dr. 
Smith was appointed a Research Physician at the 
Institute for Cancer Research in Philadelphia (1974­
FIG. 14-6. Ralph DeHoratius, M.D., explorer of 
immunologic interrelationships in rheumatology. 
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198I). During this period he received grants from 
the American Cancer Society and the National 
Institutes of Health for his studies of immune cell 
interactions in laboratory aninnls, in normal 
persons, and in patients with cancer. After joining 
the Jefferson faculty, Dr. Smith expanded his 
studies of immune ceU interactions to patients 
with rheumatic diseases. His laboratory provided 
research opportunities for Ph.D. investigators and 
Fellows in Rhnunatology. Dr. Smith also 
participated in all the clinical activities of the 
Division. 
To enhance further the expertise of the Division 
in inununology, Dr. Willis Maddrey, who had 
succeeded Dr. Frank Gray as Magee Professor of 
Medicine in 1982, and Dr. Abruzw recruited Dr. 
Henry Scovern. Dr. Scovern, a graduate of the 
George Washington University School of 
Medicine, had just completed a combined 
fellowship in allergy, immunology, and 
rheumatology at Yale before joining the Jefferson 
faculty in 1982. His research concerned the cellular 
actions and interactions associated with delayed 
hypersensitivity. In addition, he has actively 
engaged in teaching and patient care at the 
Jefferson Arthritis Center and Hospital. 
Volunteer physicians have also made important 
contributions to the Division. Dr. John R. 
Patterson (Jefferson, 1959) joined the Division as a 
part-time member in 1961. After completion of a 
residency in internal medicine at Jefferson, during 
which he devoted nine months to training in 
rheumatology, Dr. Patterson limited his practice 
to the subspeciality of rheumatology. In addition 
to teaching at the arthritis clinic, he attended the 
sarcoid clinic directed by Dr. Harold Israel. The 
sarcoid clinic provided Dr. Patterson with a 
unique opportunity to evaluate and classify 
rheumatic disease among a large group of patients 
with sarcoidosis. 
Dr. Ronald Restifo, a graduate of the Indiana 
University School of Medicine, who had been a 
fellow and staff physician in the section of 
rheumatology at the University of Pennsylvania 
Hospital, joined the Division in 1967. While at 
Jefferson he attended the arthritis clinic, 
maintained an office at the Mohler building, and 
was also active at Jefferson Hospital. A capable 
clinician and teacher, Dr. Restifo was popular 
with students, house staff, and colleagues. The call 
of the West proved irresistible, however, and 
Restifo left Jefferson in 1972 to enter private 
practice in San Jose, Calif(xma. 
A Fellowship Program was established in the 
Division in 1968. The first trainees were Drs. 
Walter Schwarzchild and Vincent Giuliano, both 
going on to the practice of rheumatology. 
Subsequent early Fellows varied in their pursuits 
with respect to practice and research. As the 
Division gained strength, research became more 
intense and innovative. Dr. Anthony Cuccinotta 
investigated bone density in patients with 
rheumatic disease. Dr. Muhammed Sadeghian, a 
graduate of the University of Teheran, worked 
with Dr. Abruzzo in the evaluation of piroxicam, 
a nonsteroidal antiinflanunatOlY drug. Sadeghian 
has continued investigations in Iran, including the 
possible value of colchicine in the management of 
calcinosis universalis. 
In 1982 the Fellowship Program was expanded 
so that a trainee was accepted every year rather 
than every two years. This format permitted the 
first-year fellow to concentrate on clinical 
activities and the second year Fellow to devote his 
or her efforts to a research project. Dr. Lawrence 
Brent (Jefferson, 1978) became the first Fellow 
under the two-year program. His studies on 1'­
lymphocytes in normal mice stimulated him to 
pursue further training in the field of immunology 
at the University of Alabama. Dr. Bruce Bender 
(Jefferson, 1977) studied monoclonal antibodies 
with specificity for HLA-DR antigens. Dr. John 
Fort studied the occurrence of anticardiolipin 
antibodies in various connective tissue diseases 
during his Fellowship, then joined the Jefferson 
full-time faculty to continue research, teaching, 
and patient care activities. The Division accepted 
its first woman Fellow in 1985, Dr. Celia 
Fernandez, from the Rutgers University School of 
Medicine. 
Jefferson's history of rheumatology is replete 
with contributions in literature, teaching and 
patient care. During the 1980s, successors to its 
pioneer rheumatologists required an environment 
supportive of research for full-time investigators 
with relatively light teaching and patient care 
responsibilities. To this end Dean Joseph Gonnella 
and Professors Willis Maddrey, Darwin Prockop, 
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and Jouni Uitto recruited a group of new faculty 
members: Drs. Sergio Jimenez, John Varga, and 
Reza Bashey. This trio provided research skills for 
the rheumatology program as well as for other 
departments engaged in the comprehensive study 
of collagen and diseases marked by coUagen 
defects and progressive fibrosis. These newcomers 
are ranked along with Cornile LeRoy and his co­
workers at the Medical University of South 
Carolina as the two groups most productive in the 
investigation of scleroderma in the United States. 
Dr. Jimenez and his colleagues joined other 
newcomers to Jefferson, Drs. Prockop 
(Biochemistry), Emanuel Rubin (Pathology), 
Maddrey (Medicine), and Uitto (Dermatology) for 
a multilateral approach to the diseases of 
connective tissue, particularly the collagen 
component. Specific diseases studied include 
osteoarthritis, osteogenesis imperfecta, and those 
associated with progressive fibrosis such as 
scleroderma and hepatic cirrhosis. 
Dr. Sergio Jimenez, a native of Peru, received 
his early training there (M.D., University of San 
Marcos, 1964, magna cum laude). Following 
internship in Lima, he came to the United States 
for training in internal medicine on the University 
of Pennsylvania service at Philadelphia General 
Hospital and later at the Mayo Clinic, returning 
to Philadelphia General Hospital as a Research 
Fellow under Dr. Darwin Prockop at the Clinical 
Research Center. Numerous publications followed 
relative to the molecular structure, biochemistry, 
synthesis, and genetic regulation of collagen. 
Jimenez was appointed to a Rheumatology 
Fellowship under Dr. ALlen Myers at the 
University of Pennsylvania School of Medicine 
and joined the teaching staff as Associate in 
Medicine in 1973. He advanced to full Professor in 
the Departments of Medicine and Orthopedic 
Surgery. In 1987 he was appointed Professor of 
Medicine and Director of Rheumatology Research 
at Jefferson, thus rejoining his early mentor, Dr. 
Prockop, who had come to Jefferson in 1986 as 
Chairman of Biochemistry and Director of the 
Jefferson Institute of Molecular Medicine. 
Dr. Jimenez has published more than TOO papers 
and has received numerous awards including the 
Gerald Rodnan Award for excellence in 
scleroderma research. 
Dr. Jolm Varga (New York University School 
of Medicine, 1980) was trained in internal 
medicine at Rhode Island Hospital. This was 
followed by a Fellowship in rheumatology under 
Dr. Alan Cohen at Boston University and a 
postdoctoral fellowship at the University of 
Pennsylvania, where he joined Dr. Jimenez in the 
study of collagen. Dr. Varga has studied 
specifically amyloidosis and scleroderma. His 
publications include chapters in three textbooks. 
Dr. Reza Bashey was educated at the University 
of Bombay (1952). He remained there for his 
M.S. in biochemistry and then went on to Rutgers 
for his Ph.D. His collagen research began at the 
University of Southern California and at the 
University of Miami, after which he had 
appointments at Albert Einstein College of 
Medicine in New York and at Hahnemann 
University, Philadelphia. In 1975 Bashey was 
appointed a senior investigator at the Philadelphia 
General Hospital Clinical Research Center, where 
he joined Dr. Jimenez and held Associate status in 
the Department of Medicine at the University of 
Pennsylvania. He continued at Pennsylvania, with 
appointments in both the Schools of Medicine and 
Dentistry, until he joined the Jefferson Faculty as 
Research Associate Professor of Medicine in 1987. 
These recent research capabilities promise 
improvements in our knowledge of the etiology of 
rheumatic diseases, with the possibility of better 
methods of treatment while at the same time 
aiding in a more comprehensive understanding of 
disease in its global relationships. 
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